{"title":"Selective Targeting of T and B Cell Populations by Alemtuzumab in the Treatment of Multiple Sclerosis","authors":"N. Grigoriadis","doi":"10.17925/ENR.2017.12.02.78","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12047,"journal":{"name":"European neurological review","volume":"12 1","pages":"78"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European neurological review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/ENR.2017.12.02.78","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}